Skip to content
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
JOIN
SEARCH
Home
Blog
Biosimilars Council Press Releases
Blog
Blog
May 18, 2021
AAM
Doug Is on the Links
Blog
May 16, 2021
AAM
McKenzie Is Dancing in the Air
Blog
May 12, 2021
AAM
Eric Is Spending Time With His Grandchildren
Blog
May 10, 2021
AAM
Raeanne Went Back to School
Blog
May 6, 2021
AAM
Michelle Is Seeing the World
Blog
April 22, 2021
AAM
Associate Member Operation Smile: A Catalyst for Increasing Access to Safe Surgery
Blog
April 14, 2021
AAM
Access! 2021 Is Coming. Here’s What You Need to Know
Blog
March 25, 2021
AAM
Women Continue to Make Health Policy History
Blog
March 25, 2021
AAM
New Analyses Point to Opportunities to Increase Savings from Biosimilar Adoption
Blog
March 23, 2021
AAM
A Roadmap for Access
Blog
March 8, 2021
AAM
Celebrating Women’s History Month
Blog
March 2, 2021
AAM
Healthy Competition in the Office—Even When We’re Not in the Office
Load More
Resources
2025 Savings Report
2025 Advocacy Priorities
2025 First Generics White Paper
Drug Shortages White Paper
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Blog
Founders Blogs
Amicus Briefs
Patient Stories
About the Association
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Community Commitment
Careers
Contact Us
Advocacy & Policy
Federal Advocacy
Biosimilars
GDUFA/BsUFA User Fees
Inflation Reduction Act
Intellectual Property & Patent Reform
Medicaid Generics Penalty
State Advocacy
Tariffs & Trade
Events
Access! 2026
GRx+Biosims 2026
Press Releases
JOIN
About
About Us
Team & Board
Generic Medicines
Our Members
Advocacy & Policy
Overview
Federal Advocacy
State Advocacy
Tariff & Trade
Biosimilars
GDUFA/BsUFA User Fees
IP & Patent Reform
Inflation Reduction Act
Medicaid Generics Penalty
Resources
Resource Center
Generic & Biosimilar
Medicines Savings Report
Advocacy Priorities
Biosimilars
Events
All Events
GRx+Biosims 2026
Access! 2027
JOIN
SEARCH
